Invention Grant
- Patent Title: Chimeric oligomeric compounds for modulation of splicing
-
Application No.: US12065250Application Date: 2006-08-29
-
Publication No.: US08501703B2Publication Date: 2013-08-06
- Inventor: C. Frank Bennett , Nicholas M. Dean , Ryszard Kole , Casey C. Kopczynski
- Applicant: C. Frank Bennett , Nicholas M. Dean , Ryszard Kole , Casey C. Kopczynski
- Applicant Address: US CA Carlsbad US MA Cambridge
- Assignee: Isis Pharmaceuticals, Inc.,Sarepta Therapeutics
- Current Assignee: Isis Pharmaceuticals, Inc.,Sarepta Therapeutics
- Current Assignee Address: US CA Carlsbad US MA Cambridge
- Agency: Isis Pharmaceuticals, Inc. Patent Dept.
- International Application: PCT/US2006/034308 WO 20060829
- International Announcement: WO2007/028065 WO 20070308
- Main IPC: A61K48/00
- IPC: A61K48/00

Abstract:
Disclosed herein are compounds, compositions and methods for modulating splicing of a selected target mRNA. Further provided are uses of the disclosed compounds and compositions in the manufacture of a medicament for treatment of diseases and disorders. Methods of enhancing cellular uptake, modulating tissue distribution and enhancing pharmacological activity of RNase H-independent antisense oligonucleotides are also provided.
Public/Granted literature
- US20110039334A1 CHIMERIC OLIGOMERIC COMPOUNDS FOR MODULATION OF SPLICING Public/Granted day:2011-02-17
Information query